Form 4: Monopar Therapeutics Director Sells Shares
Insider Transaction (Form 4)
Christopher M Starr, a Director of Monopar Therapeutics, sold 8,400 shares of common stock on October 1, 2026.
Summary
- Option exercise/conversion: acquired 8,400 Common Stock at $0.01 ($42) on October 1, 2026; holds 13,573 after (Direct).
- Open-market sale: disposed of 4,631 Common Stock at $78.09 ($361,635) on October 1, 2026; holds 8,942 after (Direct).
- Open-market sale: disposed of 2,970 Common Stock at $78.82 ($234,095) on October 1, 2026; holds 5,972 after (Direct).
- Open-market sale: disposed of 799 Common Stock at $79.67 ($63,656) on October 1, 2026; holds 5,173 after (Direct).
- Option exercise/conversion: disposed of 8,400 Stock Option on October 1, 2026; holds 8,400 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $659,387 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Christopher M Starr — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Option exercise/conversion | Common Stock | 8,400 | $0 | $42 | 13,573 |
| 2026-10-01 | Open-market sale | Common Stock | 4,631 | $78 | $361.6K | 8,942 |
| 2026-10-01 | Open-market sale | Common Stock | 2,970 | $79 | $234.1K | 5,972 |
| 2026-10-01 | Open-market sale | Common Stock | 799 | $80 | $63.7K | 5,173 |
| 2026-10-01 | Option exercise/conversion | Stock Option | 8,400 | — | — | 8,400 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Option exercise/conversion (8,400 shares) |
| 2026-10-01 | Open-market sale (4,631 shares) |
| 2026-10-01 | Open-market sale (2,970 shares) |
| 2026-10-01 | Open-market sale (799 shares) |
| 2026-10-01 | Option exercise/conversion (8,400 shares) |
Keywords
insider transaction, Form 4, MNPR, Monopar Therapeutics, bearish, Christopher M Starr
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.